Design (Testphase)
Value & GARP
Joel Greenblatt: Magic Formula
25
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
The simplified screener version of Greenblatt's "The Little Book That Beats the Market": above-average companies (return on capital ≥ 25%, approximated as ROE × equity ratio) at below-average prices (positive P/E, at least 5 to filter out data outliers). Financials and utilities are excluded as in the original, minimum market cap $50 million. Source: fundamental data.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- ROE (Return on Equity)
- Profit divided by equity: how much return does the company generate on its owners' money? Consistently above 15-20% is considered a hallmark of top-tier companies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MU Micron Technology Inc | — | +511 % | 97 12/25 | Stage 2 | A 92 | 6 of 9 | 1,069.1 $ | Semiconductors | Sells AI | — | Technology | 823.00 $ | +268.7 % | +299.8 % | +655.3 % | −3.3 % | +85.0 % | 99 | 96 | 10.6 % | 9.5 % | 2.14 | 17.4 | 5.3 | 18.4 | 8.6 | 27.2 | 0.12 | 13.3 | 80.4 % | 72.6 % | 55.9 % | 39.8 % | 34.9 % | 0.06 | 75.1 % | +48.9 % | — | 0.1 % | 1.2 % | 11.7 | 81.6 % | 3.2 % | 4.5 (37) | |
| SNDK Sandisk Corp | 08/13 | — | 91 10/25 | Stage 2 | A 80 | 7 of 9 | 208.3 $ | Computer Hardware | Uses AI | — | Technology | 1,214.80 $ | +727.2 % | +719.9 % | +2,730.5 % | −0.8 % | +82.6 % | 99 | 96 | 10.9 % | 9.6 % | — | 41.6 | 18.9 | 15.8 | 13.1 | 46.7 | — | 32.6 | 70.0 % | 56.0 % | 34.2 % | 39.3 % | 22.8 % | 0.02 | 80.7 % | +10.4 % | — | 0.0 % | 0.0 % | 13.0 | 80.8 % | 8.3 % | 3.8 (12) | |
| WDC Western Digital Corporation | 07/29 | +752 % | 86 9/25 | Stage 2 | A 88 | 6 of 9 | 205.1 $ | Computer Hardware | Uses AI | — | Technology | 544.80 $ | +289.6 % | +263.3 % | +594.3 % | −15.6 % | +20.3 % | 99 | 95 | 11.5 % | 8.3 % | 2.17 | 28.3 | 28.6 | 17.4 | 16.8 | 70.6 | 0.48 | 24.5 | 37.0 % | 45.4 % | 55.3 % | 85.9 % | 14.6 % | 0.32 | 64.3 % | +50.7 % | — | 0.1 % | 7.5 % | 10.8 | 101.2 % | 7.6 % | 4.5 (25) | |
| LRCX Lam Research Corp | 07/29 | +176 % | 71 7/25 | Stage 2 | A 80 | 8 of 9 | 404.1 $ | Semiconductor Equipment & Materials | Uses AI | — | Technology | 293.00 $ | +117.3 % | +132.2 % | +210.7 % | −1.9 % | +25.6 % | 96 | 75 | 7.4 % | 6.9 % | 1.81 | 52.1 | 32.1 | 18.6 | 32.7 | 62.6 | 1.38 | 42.2 | 35.0 % | 50.5 % | 31.3 % | 66.8 % | 22.8 % | 0.35 | 50.9 % | +23.7 % | — | 0.4 % | 17.9 % | 14.5 | 88.1 % | 2.6 % | 4.3 (33) | |
| CRDO Credo Technology Group Holding Ltd | 09/02 | +487 % | 72 7/25 | Stage 2 | A 87 | 7 of 9 | 38.5 $ | Semiconductors | Sells AI | — | Technology | 207.00 $ | +89.0 % | +63.6 % | +85.6 % | −13.2 % | +34.9 % | 96 | 93 | 10.5 % | 11.3 % | 3.20 | 83.7 | 35.1 | 28.8 | 18.8 | 94.6 | — | 77.5 | 35.7 % | 68.0 % | 35.4 % | 34.4 % | 17.9 % | 0.01 | 89.9 % | +205.7 % | — | 0.0 % | 0.0 % | 19.7 | 75.9 % | 3.6 % | 4.6 (13) | |
| KLAC KLA Corporation | 07/30 | +150 % | 86 9/25 | Stage 2 | A 75 | 6 of 9 | 238.8 $ | Semiconductor Equipment & Materials | Uses AI | — | Technology | 182.80 $ | +101.7 % | +118.6 % | +109.3 % | −89.4 % | +26.3 % | 94 | 60 | 7.6 % | 6.9 % | 1.41 | 49.8 | 33.8 | 18.2 | 41.0 | 59.5 | 1.75 | 38.2 | 41.2 % | 61.3 % | 35.6 % | 95.0 % | 20.8 % | 1.52 | 34.6 % | +23.9 % | — | 0.5 % | 21.3 % | 9.6 | 93.8 % | 2.4 % | 4.1 (30) | |
| TGTX TG Therapeutics Inc | 08/03 | +43 % | 53 5/22 | Stage 2 | B 68 | 5 of 9 | 8.0 $ | Biotechnology | Neutral | — | Healthcare | 52.00 $ | +80.9 % | +79.3 % | +46.6 % | −6.5 % | +31.6 % | 90 | 92 | 5.0 % | 4.8 % | 1.60 | 18.9 | 55.2 | 11.5 | 14.2 | — | 1.61 | 54.6 | 17.0 % | 83.1 % | 66.0 % | 112.6 % | 8.6 % | 1.29 | 38.1 % | +87.3 % | — | 0.0 % | 0.0 % | 6.2 | 70.2 % | 29.0 % | 4.3 (9) | |
| MSGE Madison Square Garden Entertainment Corp. | 08/12 | +45 % | 35 4/24 | Stage 2 | B 56 | 6 of 9 | 3.6 $ | Entertainment | Neutral | — | Communication Services | 77.30 $ | +41.8 % | +48.6 % | +104.5 % | −0.6 % | +4.4 % | 86 | 18 | 4.0 % | 3.0 % | 0.55 | 72.8 | 27.5 | 3.5 | 77.6 | 11.0 | — | 25.2 | 10.3 % | 46.9 % | 4.8 % | 170.3 % | 5.0 % | 0.08 | 53.2 % | -1.7 % | — | 0.0 % | 0.0 % | 4.1 | 102.1 % | 3.8 % | 4.4 (9) | |
| AUPH Aurinia Pharmaceuticals Inc | 07/30 | +31 % | 28 3/22 | Stage 2 | A 82 | 6 of 9 | 1.9 $ | Biotechnology | Neutral | — | Healthcare | 14.90 $ | +12.1 % | +3.2 % | +61.0 % | −8.8 % | +14.1 % | 83 | 79 | 5.6 % | 4.2 % | 1.42 | 6.9 | 17.0 | 6.3 | 3.4 | 11.3 | — | 10.2 | 53.3 % | 78.3 % | 100.0 % | 65.0 % | 13.7 % | 0.12 | 78.4 % | +20.4 % | — | 0.0 % | 0.0 % | 9.2 | 60.3 % | 8.4 % | 4.3 (6) | |
| GOOGL Alphabet Inc Class A | 07/22 | +62 % | 21 3/24 | Stage 2 | B 73 | 6 of 9 | 4,345.3 $ | Internet Content & Information | Sells AI | — | Communication Services | 356.10 $ | +10.7 % | +12.7 % | +86.1 % | −15.9 % | +19.9 % | 79 | 83 | 3.8 % | 3.1 % | 1.25 | 26.6 | 17.4 | 10.3 | 9.1 | 67.4 | 0.97 | 13.0 | 36.1 % | 60.9 % | 54.8 % | 38.9 % | 13.0 % | 0.22 | 68.0 % | +15.1 % | — | 0.3 % | 4.3 % | 10.1 | 80.8 % | 1.3 % | 4.4 (68) | |
| GOOG Alphabet Inc Class C | 07/22 | +61 % | 10 2/24 | Stage 2 | B 73 | 6 of 9 | 4,386.6 $ | Internet Content & Information | Sells AI | — | — | Communication Services | 356.70 $ | +10.4 % | +11.4 % | +85.5 % | −15.4 % | +18.2 % | 79 | 83 | 3.6 % | 3.1 % | 1.25 | 26.6 | 17.4 | 9.8 | 8.9 | 82.3 | 0.97 | 13.0 | 36.1 % | 60.9 % | 54.8 % | 38.9 % | 13.0 % | 0.22 | 68.0 % | +15.1 % | — | 0.3 % | 4.3 % | 10.1 | 61.1 % | 0.3 % | 4.4 (68) |
| LLY Eli Lilly and Company | 08/06 | +49 % | 67 6/22 | Stage 2 | A 83 | 8 of 9 | 1,024.4 $ | Drug Manufacturers - General | Uses AI | — | Healthcare | 1,148.80 $ | +3.4 % | +14.6 % | +56.3 % | −4.7 % | +11.2 % | 72 | 89 | 3.1 % | 3.3 % | 0.51 | 43.7 | 33.9 | 14.2 | 32.8 | 75.4 | 1.61 | 29.3 | 49.4 % | 82.8 % | 35.0 % | 107.5 % | 20.7 % | 1.73 | 26.8 % | +44.7 % | — | 0.6 % | 29.0 % | 7.3 | 85.4 % | 1.2 % | 4.3 (31) | |
| EXEL Exelixis Inc | 07/27 | +53 % | 53 5/22 | Stage 2 | B 73 | 8 of 9 | 13.3 $ | Biotechnology | Neutral | — | Healthcare | 53.00 $ | +17.1 % | +16.7 % | +46.4 % | −1.3 % | -1.8 % | 69 | 76 | 3.3 % | 3.1 % | 0.42 | 18.1 | 16.8 | 5.6 | 6.9 | 14.5 | 2.27 | 12.9 | 41.2 % | 96.4 % | 35.1 % | 41.0 % | 22.0 % | 0.09 | 74.6 % | +7.0 % | — | 0.0 % | 0.0 % | 10.7 | 107.5 % | 16.7 % | 3.9 (20) | |
| KEX Kirby Corporation | 07/30 | +30 % | 90 11/29 | Stage 2 | B 58 | 6 of 9 | 7.0 $ | Marine Shipping | Neutral | — | Industrials | 131.10 $ | +25.5 % | +24.0 % | +37.6 % | −12.1 % | +26.7 % | 68 | 60 | 2.2 % | 2.4 % | 0.83 | 19.9 | 17.9 | 2.1 | 2.1 | 14.1 | 2.63 | 15.8 | 13.3 % | 33.2 % | 10.2 % | 10.7 % | 5.3 % | — | 5,889.4 % | +3.0 % | — | 0.0 % | 0.0 % | — | 103.0 % | 3.8 % | 5.0 (5) | |
| AAPL Apple Inc | 07/30 | +20 % | 77 8/25 | Stage 2 | B 67 | 8 of 9 | 4,536.9 $ | Consumer Electronics | Uses AI | — | Technology | 308.90 $ | +8.5 % | +3.1 % | +49.4 % | −13.3 % | +4.7 % | 65 | 67 | 2.9 % | 2.5 % | 1.10 | 38.6 | 31.9 | 9.7 | 42.6 | 33.2 | 2.46 | 27.1 | 32.3 % | 48.7 % | 27.6 % | 141.5 % | 27.1 % | 0.80 | 28.7 % | +6.4 % | — | 0.4 % | 12.3 % | 6.6 | 65.8 % | 1.0 % | 4.0 (48) | |
| NVDA NVIDIA Corporation | 08/26 | +125 % | 71 7/25 | Stage 2 | A 85 | 7 of 9 | 5,072.9 $ | Semiconductors | Sells AI | — | Technology | 200.80 $ | +7.4 % | +3.5 % | +13.0 % | −17.3 % | +50.8 % | 62 | 91 | 3.2 % | 3.6 % | 2.21 | 30.2 | 22.9 | 20.0 | 24.5 | 42.6 | 0.55 | 24.8 | 65.6 % | 74.2 % | 63.0 % | 114.3 % | 52.7 % | 0.07 | 75.3 % | +65.5 % | — | 0.5 % | 4.8 % | 16.4 | 70.9 % | 1.4 % | 4.5 (63) | |
| FAST Fastenal Company | 07/14 | +24 % | 48 6/29 | Stage 2 | B 64 | 8 of 9 | 55.1 $ | Industrial Distribution | – | — | — | Industrials | 47.70 $ | +14.9 % | +14.6 % | +5.7 % | −7.3 % | +0.3 % | 41 | 61 | 2.4 % | 2.2 % | 0.71 | 42.6 | 38.2 | 6.3 | 13.8 | 47.6 | 3.45 | 28.1 | 20.3 % | 44.7 % | 15.5 % | 33.8 % | 21.5 % | 0.11 | 76.6 % | +8.7 % | — | 2.0 % | 81.4 % | 14.9 | 88.2 % | 3.1 % | 3.2 (16) |
| DECK Deckers Outdoor Corporation | 07/23 | +8 % | 8 2/31 | Stage 1 | B 57 | 4 of 9 | 13.5 $ | Footwear & Accessories | Uses AI | — | Consumer Cyclical | 96.90 $ | +0.0 % | +0.3 % | -8.8 % | −18.9 % | +26.7 % | 34 | 29 | 4.1 % | 3.9 % | 1.17 | 14.1 | 12.9 | 2.4 | 5.4 | 11.2 | 1.19 | 8.7 | 14.0 % | 57.8 % | 18.4 % | 40.9 % | 20.3 % | 0.15 | 67.8 % | +9.4 % | — | 0.0 % | 0.0 % | 13.5 | 100.8 % | 6.0 % | 3.8 (24) | |
| TPL Texas Pacific Land Corporation | 08/05 | +58 % | 25 1/10 | Stage 1 | B 69 | 4 of 9 | 27.1 $ | Oil & Gas E&P | – | — | — | Energy | 402.60 $ | +29.1 % | +42.3 % | +25.5 % | −64.0 % | +10.2 % | 33 | 64 | 4.4 % | 4.4 % | 0.59 | 55.4 | 37.7 | 32.3 | 17.8 | 55.0 | 7.33 | 39.0 | 77.2 % | 93.2 % | 60.0 % | 36.5 % | 25.2 % | 0.01 | 88.8 % | +13.1 % | — | 0.6 % | 24.8 % | 18.4 | 74.9 % | 9.1 % | 3.0 (2) |
| ACAD ACADIA Pharmaceuticals Inc | 08/05 | -3 % | 13 2/22 | Stage 1 | B 56 | 5 of 9 | 4.3 $ | Biotechnology | Uses AI | — | Healthcare | 25.90 $ | -15.4 % | -9.6 % | +8.6 % | −16.3 % | +27.2 % | 32 | 6 | 4.6 % | 3.5 % | 0.80 | 12.5 | 77.5 | 4.0 | 3.8 | 20.4 | 50.86 | 39.2 | -1.7 % | 61.6 % | 34.3 % | 37.3 % | 3.7 % | 0.04 | 77.8 % | +11.9 % | — | 0.0 % | 0.0 % | 7.0 | 99.1 % | 10.2 % | 4.0 (20) | |
| APP Applovin Corp | 08/05 | +632 % | 83 8/24 | Stage 4 | A 82 | 9 of 9 | 133.7 $ | Advertising Agencies | – | — | — | Communication Services | 395.90 $ | -30.7 % | -31.4 % | +1.3 % | −40.2 % | +65.3 % | 31 | 87 | 6.5 % | 6.6 % | 2.48 | 36.0 | 25.1 | 21.7 | 58.7 | 30.4 | 1.09 | 27.1 | 78.1 % | 88.4 % | 64.3 % | 266.4 % | 44.2 % | 4.18 | 30.7 % | +70.0 % | — | 0.0 % | 0.0 % | 11.6 | 75.0 % | 4.3 % | 4.3 (26) |
| IDXX IDEXX Laboratories Inc | 08/03 | +4 % | 24 3/22 | Stage 4 | B 67 | 7 of 9 | 44.5 $ | Diagnostics & Research | – | — | — | Healthcare | 559.10 $ | -20.0 % | -22.1 % | +4.6 % | −27.9 % | +26.5 % | 23 | 63 | 3.3 % | 3.0 % | 1.55 | 40.9 | 37.9 | 10.0 | 28.2 | 41.2 | 3.58 | 28.9 | 31.8 % | 62.1 % | 24.6 % | 72.9 % | 26.5 % | 0.97 | 46.0 % | +10.4 % | — | 0.0 % | 0.0 % | 13.7 | 96.2 % | 3.0 % | 3.6 (13) |
| MANH Manhattan Associates Inc | 07/28 | -10 % | 46 5/25 | Stage 4 | C 51 | 5 of 9 | 11.2 $ | Software - Application | – | — | — | Technology | 191.40 $ | -24.9 % | -21.2 % | -12.9 % | −48.3 % | +8.2 % | 13 | 30 | 4.8 % | 4.7 % | 0.97 | 57.6 | 36.2 | 9.9 | 59.4 | 28.1 | 2.30 | 38.2 | 23.0 % | 55.8 % | 18.7 % | 96.2 % | 24.5 % | 0.39 | 27.7 % | +3.8 % | — | 0.0 % | 0.0 % | 7.8 | 113.3 % | 6.3 % | 4.2 (10) |
| PLTR Palantir Technologies Inc. | 08/03 | +244 % | 72 7/25 | Stage 4 | A 87 | 8 of 9 | 302.2 $ | Software - Infrastructure | – | — | — | Technology | 123.10 $ | -34.3 % | -40.4 % | -22.3 % | −48.3 % | +48.0 % | 10 | 93 | 5.3 % | 4.9 % | 1.56 | 145.6 | 84.0 | 57.8 | 36.8 | 112.4 | 1.76 | 142.3 | 46.2 % | 84.1 % | 43.7 % | 32.6 % | 14.7 % | 0.03 | 82.9 % | +56.2 % | — | 0.0 % | 0.0 % | 14.6 | 62.4 % | 3.6 % | 2.9 (25) |
| ADMA ADMA Biologics Inc | 08/05 | +42 % | 40 4/22 | Stage 4 | B 63 | 7 of 9 | 2.0 $ | Biotechnology | – | — | — | Healthcare | 8.50 $ | -52.4 % | -57.2 % | -54.8 % | −57.4 % | +100.0 % | 4 | 14 | 4.2 % | 4.0 % | 0.73 | 12.5 | 10.2 | 3.9 | 5.0 | 18.2 | — | 9.2 | -123.4 % | 61.3 % | 32.4 % | 43.3 % | 22.0 % | 0.52 | 58.7 % | +19.6 % | — | 0.0 % | 0.0 % | 10.6 | 94.0 % | 12.7 % | 4.3 (3) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
The simplified screener version of Greenblatt's "The Little Book That Beats the Market": above-average companies (return on capital ≥ 25%, approximated as ROE × equity ratio) at below-average prices (positive P/E, at least 5 to filter out data outliers). Financials and utilities are excluded as in the original, minimum market cap $50 million. Source: fundamental data.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 25 stocks pass this scanner's criteria (as of 3. August 2026).
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.